Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New shoulder surgery technique may spare rotator cuff and speed recovery

NCT ID NCT01961986

Symptom relief Sponsor: NYU Langone Health Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study compares a newer surgical approach that spares the rotator cuff to the traditional method for total shoulder replacement in 108 adults with arthritis. The goal is to see which approach leads to better shoulder function and recovery. Participants will be followed for at least two years after surgery.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

108 people

The number who actually took part.

Started

Jul 2010

Expected to finish

May 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

21 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Patient is indicated for shoulder joint replacement * Patient is at least 21 years of age * Patient is expected to survive at least 2 years beyond surgery * Patient is willing to participate by complying with pre-and post-operative visit requirements * Patient is willing and able to review and sign a study informed consent form Exclusion Criteria: * Prior arthroplasty in the affected shoulder. * Significant deformity of the proximal humerus that requires a custom made implant or where osteotomy of the shaft and / or the tuberosity has to be considered. * Significant medial erosion of the glenoid such that lateral edge of the humeral head lies medial to the lateral rim of the acromion. * Significant injury to the brachial plexus * Inability or unwillingness to participate in the post operative evaluation for the entire 24 months period. * Pregnant and lactating women will be excluded

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Inflammatory arthritis are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

arthritic joint disease osteoarthritis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Inflammatory arthritis Osteoarthritis

Contacts and locations

Locations

  • NYU Hospital for Joint Diseases

    New York, New York, 10003, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.